Cargando…
Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry
OBJECTIVE: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) have been shown to reduce the risk of cardiovascular complications, which largely drive diabetes’ health and economic burdens. Trial results indicated that SGLT2i are cost effective. However, these findings may not be generalizable to the...
Autores principales: | Li, Xinyu, Hoogenveen, Rudolf, El Alili, Mohamed, Knies, Saskia, Wang, Junfeng, Beulens, Joline W. J., Elders, Petra J. M., Nijpels, Giel, van Giessen, Anoukh, Feenstra, Talitha L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492753/ https://www.ncbi.nlm.nih.gov/pubmed/37300652 http://dx.doi.org/10.1007/s40273-023-01286-3 |
Ejemplares similares
-
The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
por: Emamipour, Sajad, et al.
Publicado: (2022) -
Prediction of complications in health economic models of type 2 diabetes: a review of methods used
por: Li, Xinyu, et al.
Publicado: (2023) -
A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspective
por: Emamipour, Sajad, et al.
Publicado: (2020) -
Prognostic models for predicting the risk of foot ulcer or amputation in people with type 2 diabetes: a systematic review and external validation study
por: Beulens, Joline W. J., et al.
Publicado: (2021) -
Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting
por: van der Heijden, Amber A., et al.
Publicado: (2020)